Parexel Upbeat After Strong Quarter, Acquisition of Heron
With a more than 27 percent increase in revenue for Q3 of FY 2013 over the same quarter last year, CRO Parexel has raised its guidance for both the fiscal and calendar year.
Archives for May 6, 2013
Pfizer Sells On-Line to Dampen Fake Viagra's Rise
Pfizer has begun selling Viagra online in order to counter the trade in fake versions of its erectile dysfunction drug.
PE group invests in Australia's Novotech
US private-equity group Mercury Capital has bought a 30 per cent stake in Australian CRO Novotech.
Another US Plant Closure in Cost-Saving Plan as Teva Eyes Head 'East'
Teva will close a second US plant and shift manufacture to more cost effective facilities as part of its company-wide restructuring programme.
FDA Releases Alexion Response to Form 483 on Microbial Contaminations
In a rare move, the FDA has publically released Alexion Pharmaceuticals’ response to a Form 483 following inspection of its US site and the discovery of microbial contamination.
BASF and Chemport Get US OK as Amarin API Suppliers
API makers Chemport and BASF have been cleared by US regulators to supply Amarin with omega-3 for its heart drug Vascepa.
Derma Acquisitions and Need for Development Drive MedPharm Investment
MedPharm has opened a new laboratory in response to high demand for its preclinical dermatological services.
DISPATCHES FROM INTERPHEX
AlpVision's iPhone Tech Offers Authentication in War on Counterfeits
In the war against counterfeits, regulators have concentrated on serialisation and ePedigree and missed an opportunity on product authentication, according to AlpVision.